awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38012156-22649C1A-E30D-444A-B9FA-33761BB5682C
Q38012156-22649C1A-E30D-444A-B9FA-33761BB5682C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38012156-22649C1A-E30D-444A-B9FA-33761BB5682C
Sorafenib in locally advanced or metastatic breast cancer.
P2860
Q38012156-22649C1A-E30D-444A-B9FA-33761BB5682C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38012156-22649C1A-E30D-444A-B9FA-33761BB5682C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2b297d69d9763c5a34f938768b5c44a3bec989f1
P2860
RIBBON-1: randomized, double-blind, placebo-controlled, phase III trial of chemotherapy with or without bevacizumab for first-line treatment of human epidermal growth factor receptor 2-negative, locally recurrent or metastatic breast cancer.